uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted November 29, 2019

FDA Warns Seller of "All Natural" Treatment for Opioid Withdrawal, Migraines & More

On November 18, 2019, the FDA issued a warning letter to EPH Technologies, Inc., following a review of the company's websites, which found statements made about some of the company's products, including Detoxoplex, Sinople, and Migrenz, to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at